Clover Health Investments, Corp. (CLOV) stock
Close on Nov 12, 2026Market cap $2.59BP/E 488.0Yield –
Clover Health Investments, Corp. grew revenue 54.5% to $2.74B over the twelve months to Sep 30, 2026. Free cash flow was $132.28M. At the latest close the market valued the company at $2.59B, 488.0 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $2.59B
- P/E ratio
- 488.0
- Price to sales
- 0.95
- Price to book
- 6.63
- Dividend yield
- –
- Free cash flow yield
- 5.10%
Fundamentals
- Revenue
- $2.74B
- Net income
- $12.45M
- EPS, diluted
- $0.01
- Free cash flow
- $132.28M
- Book value per share
- $0.70
- Diluted shares
- 557M
Trading
- Next earnings
- Feb 25, 2027 (estimated, after the close)
- Previous close
- $4.97
- Open
- $4.92
- Day's range
- $4.86 – $5.03
- Volume
- 4,138,510
- Average volume (20 days)
- 4,552,538
- Index membership
- Russell 2000 (since Jun 2025), Russell 3000 (since Aug 2025)
- Beta (5 years)
- 1.66
- 52-week range
- $1.58 – $5.59
- RSI (14 days)
- 56.6
- Volatility (1 year)
- 59.5%
- Relative volume
- 0.94×
- WACC
- 13.2%
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2020, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | CLOV | S&P 500 | Difference | CLOV per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +2.1% | -2.7% | +4.8 pts | ||
| 3 months | +7.5% | -1.7% | +9.2 pts | ||
| Year to date | +107.7% | +11.9% | +95.8 pts | ||
| 1 year | +94.4% | +12.0% | +82.4 pts | ||
| 3 years | +440.4% | +78.2% | +362.2 pts | +75.5% | +21.2% |
| 5 years | -31.8% | +73.2% | −105.1 pts | -7.4% | +11.6% |
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Clover Health Investments filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- Results
- Update
- Results
About Clover Health Investments
Hospital & Medical Service Plans
Clover Health operates as a healthcare technology and insurance company focused on empowering physicians with proprietary software to detect, manage, and treat chronic conditions. Its primary insurance offerings include Medicare Advantage Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans, alongside specialized programs like Clover Home Care for complex patients. The company also offers Counterpart Assistant, a clinician-centric software-as-a-service and technology-enabled platform licensed to external payors and providers. Clover Health primarily serves Medicare-eligible beneficiaries, particularly seniors with chronic diseases and individuals residing in historically underserved communities.
Company profile, executives and historyClover Health Investments stock: common questions
What is Clover Health Investments's stock price?
CLOV closed at $4.88 on Nov 12, 2026, down 1.81% on the day. Over the past 52 weeks it traded between $1.58 and $5.59.
What is Clover Health Investments's market cap?
Clover Health Investments was worth $2.59B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is CLOV's P/E ratio?
CLOV trades at 488.0 times earnings, based on diluted earnings per share of $0.01 over the twelve months to Sep 30, 2026.
How much revenue does Clover Health Investments make?
Clover Health Investments reported revenue of $2.74B for the twelve months to Sep 30, 2026, up 54.5% from a year earlier.
Does Clover Health Investments pay a dividend?
No. Clover Health Investments has not paid a cash dividend over the last twelve months.
When does Clover Health Investments report earnings next?
Clover Health Investments is expected to report Q4 FY2026 results on Feb 25, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has CLOV stock performed over the past year?
Including dividends, CLOV returned +94.4% over the past year, against +12.0% for the S&P 500.
How many CLOV shares are sold short?
23M shares were sold short at the latest FINRA report, 5.67% of the float, or 6.7 days of average trading volume.
Who are Clover Health Investments's competitors?
Companies most similar to Clover Health Investments by business, industry and size include ALHC, OSCR, TRUP, MOH, CNO.
See a number that looks wrong?